【ChiCTR2100050048】Sex Differences in Primary Malignant Cardiac Tumors: A Multi-Institutional Study from National Cancer Database
ChiCTR2100050048
尚未开始
/
/
/
2021-08-16
/
/
Primary Malignant Cardiac Tumors
Sex Differences in Primary Malignant Cardiac Tumors: A Multi-Institutional Study from National Cancer Database
Sex Differences in Primary Malignant Cardiac Tumors: A Multi-Institutional Study from National Cancer Database
Despite the significant clinical importance of sex among factors affecting cancer progression and survival, it remains one of the least studied factors. Primary malignant cardiac tumors (PMCTs) are rare neoplasms with dismal outcomes. Despite the increased emphasis on personalized medicine, still few studies report sex distinction outcomes. Therefore, we sought to examine these differences in relation to PMCTs using a national dataset.
连续入组
回顾性研究
The 2004-2018 National Cancer Database (NCDB) will be queried for patients with PMCTs.
N/A
Weill Cornell Medicine
/
1000
/
2021-08-02
1990-01-01
/
Primary Malignant Cardiac Tumors PMCTs;
请登录查看All tumors with sequence of malignant neoplasms of more than 1 over the lifetime of the patient and those with missing survival time or status were excluded.;
请登录查看美国纽约威尔康乃尔医学院
/
美国纽约威尔康乃尔医学院的其他临床试验
美国纽约威尔康乃尔医学院的其他临床试验
- Dr. Shon Shmushkevich, please upload the approved file of ethical committee. Association of disparity in insurance status with late survival in cardiac tumors: a multi-institutional cohort study from National Cancer Database
- Sex Differences in Primary Malignant Cardiac Tumors: A Multi-Institutional Study from National Cancer Database
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
